Opendata, web and dolomites

Clarity SIGNED

Real-time renal diagnostic to prevent ICU-acquired Acute Kidney Injury (AKI).

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Clarity project word cloud

Explore the words cloud of the Clarity project. It provides you a very rough idea of what is the project "Clarity" about.

57    outcomes    practiced    acute    alerts    efficacy    renal    market    24    patient    flow    kidney    injury    herzog    13    interprets    risk    clinical    global    patented    electronic    data    basis    facilitates    reflects    serious    lost    secured    provides    feasible    hospital    prevalent    ing    intensive    introduces    days    rapid    balance    people    treatment    aki    invaluable    disease    rms    variably    nursing    hadassah    critical    industrialization    volume    tested    curative    significantly    feasibility    trade    sign    staff    medical    showed    patients    fluctuations    die    limit    sensor    million    composition    decade    renalsense    fluid    gbd    automatically    additional    clarity    time    requiring    strategy    care    morbidity    intervention    organisation    prevent    worldwide    acquired    hours    plan    develops    function    changing    monitoring    icu    pittsburgh    university    trials    therapy    records    transmitting    unfortunately    accurate    burden    prevention    urine    mortality    consistent   

Project "Clarity" data sheet

The following table provides information about the project.

Coordinator
RENAL SENSE LTD 

Organization address
address: HAMARPE 3
city: JERUSALEM
postcode: 91450
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2020-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RENAL SENSE LTD IL (JERUSALEM) coordinator 50˙000.00

Map

 Project objective

Intensive Care Unit (ICU)-acquired Acute Kidney Injury (AKI) is a prevalent and serious problem, associated with significantly increased morbidity and mortality. According to the Global Burden of Disease (GBD), each year around 1.7 million people worldwide are estimated to die from AKI. AKI develops in over 57% of ICU patients, requiring an average of 3.5 additional hospital days and €13,000 of additional hospital costs per patient. The best treatment for AKI is prevention. Although there is no curative therapy for AKI, research over the past decade identified various means to prevent or limit AKI. Unfortunately, these are not widely known and are variably practiced worldwide resulting in lost opportunities to improve the care and outcomes of patients with AKI. RenalSense introduces Clarity RMS™, a critical care monitoring system that continuously measures urine flow, automatically transmitting to the medical staff real-time data and alerts of fluctuations, on a 24/7 basis. Using patented sensor technology, Clarity measures, analyses and interprets the continuously changing composition and flow volume of urine. This information, which reflects changes in renal function, provides an early sign of AKI risk and facilitates rapid intervention. In addition, it is invaluable for monitoring treatment efficacy and managing fluid balance. The system has been tested during clinical trials with Herzog hospital, Hadassah Medical Organisation and University of Pittsburgh. Analysis of 1,000 study hours showed that electronic measurements with Clarity were more consistent, reliable and accurate than nursing records. During the feasibility assessment, RenalSense will establish a go-to-market strategy, as well as a feasible product development plan and industrialization strategy. The plan for the large-scale clinical trials will be defined, and the participants secured.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLARITY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLARITY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

C-Air (2018)

An innovative, reliable, lifesaving industrial air purification system that contains, cleans, and purifies air contaminated by toxic gases.

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More